Dergiler / Neurological sciences and neurophysiology (Online) / 2019 / Cilt: 36 - Sayı: 4

Biomarkers of neuronal damage and inflammation in delirium

Sayfa
193–197
DOI
—
🏛️Bu makalenin bibliyografik verileri ve tam metin bağlantısı DergiPark üzerinden sağlanmıştır.
DergiPark Kaydı ↗
✨

Yapay Zeka Hızlı Bakış & Çıkarımlar

AI Insight
⚡ TL;DR(1 Cümlede Hızlı Çıkarım)

We also found that delirium motor subtypes differed from each other with elevated IL-6 levels in hyperactive and mixed-type delirium.

📌 3 Maddede Bu Makale

🎯
Amaç & Hipotez:Objective: Inflammatory response and neuronal damage seem to be a part of the pathogenesis of delirium, but the exact mechanism, especially in motor subtypes of delirium, remains unclear.
📊
Temel Bulgular & Veri:Methods: This study included 53 patients with delirium and 50 intensive care unit patients without delirium.
💡
Sonuç & Katkı:We also found that delirium motor subtypes differed from each other with elevated IL-6 levels in hyperactive and mixed-type delirium.
🔬Tür:Araştırma Makalesi
📍Kapsam:Genişletilmiş Akademik Örneklem
⚙️Değişkenler:Alan Parametreleri

Özet

Objective: Inflammatory response and neuronal damage seem to be a part of the pathogenesis of delirium, but the exact mechanism, especially in motor subtypes of delirium, remains unclear. Methods: This study included 53 patients with delirium and 50 intensive care unit patients without delirium. Interleukin (IL)-6, Neuron-specific enolase (NSE), and S100 beta (S100B) blood levels were examined in both groups. Patients with delirium were also investigated according to the delirium motor subtypes. Results: There was no difference between the delirium and control groups with regard to S100B and NSE. However, the IL-6 levels of patients with delirium were significantly higher than those of the controls [24.73 pg/mL (2.91-99.36) vs. 5.44 pg/mL (2.75-89.32), p<0.001]. In a comparison of the subgroups of delirium, no statistical significance was found except that the IL-6 levels of hypoactive patients were delirium [10.46 pg/mL (2.91-99.36)] were lower than those of patients with hyperactive [30.97 pg/mL (10.66-88.21), p=0.03] and mixed delirium [50.18 pg/mL (17.22-66.55), p=0.02]. Conclusion: Our data suggest that delirium was associated with elevated blood levels of proinflammatory cytokine IL-6, but not with neuronal damage biomarkers S100B and NSE. We also found that delirium motor subtypes differed from each other with elevated IL-6 levels in hyperactive and mixed-type delirium.

🔖

Bu Makaleye Atıf Yap

ÖZKUL, A., YILMAZ, A., AKYOL, A., KAAN, N., YENİSEY, Ç., CEYLAN, A., KURT, İ. (2019). Biomarkers of neuronal damage and inflammation in delirium. Neurological sciences and neurophysiology (Online), Cilt: 36 - Sayı: 4, 193–197. https://ajindex.com/articles/290534

📄 Tam Metin PDF Okuyucu

📄

PDF görüntüleyici hazırlanıyor...

Kaynakça (1)

  1. Maclullich AM, Ferguson KJ, Miller T, de Rooij SE, Cunningham C. Unravelling the pathophysiology of delirium: a focus on the role of aberrant stress responses. J Psychosom Res 2008; 65:229-238. [CrossRef] 2. Eikelenboom P, Hoogendijk WJ, Jonker C, van Tilburg W. Immuno-logical mechanisms and the spectrum of psychiatric syndromes in Alzheimer's disease. J Psychiatr Res 2002; 36: 269-280. [CrossRef] 3. de Rooij SE, van Munster BC, Korevaar JC, Levi M. Cytokines and acute phase response in delirium. J Psychosom Res 2007; 62: 521-525. [CrossRef] 4. Cunningham C, Campion S, Lunnon K, et al. Systemic inflam-mation induces acute behavioral and cognitive changes and accelerates neurodegenerative disease. Biol Psychiatry 2009; 65: 304-312. [CrossRef] 5. van Munster BC, Bisschop PH, Zwinderman AH, Korevaar JC, Endert E, Wiersinga WJ, van Oosten HE, Goslings JC, de Rooij SE. Cortisol, interleukins and S100B in delirium in the elderly. Brain Cogn 2010;74:18-23. [CrossRef] 6. Gunther ML, Morandi A, Ely EW. Pathophysiology of delirium in the intensive care unit. Crit Care Clin 2008; 24: 45-65. [CrossRef] 7. Gonçalves CA, Leite MC, Nardin P. Biological and methodologi-cal features of the measurement of S100B, a putative marker of brain injury. Clin Biochem 2008; 41: 755-763. [CrossRef] 8. Fanò G, Biocca S, Fulle S, Mariggiò MA, Belia S, Calissano P. The S-100: a protein family in search of a function. Prog Neurobiol 1995; 46: 71-82. [CrossRef] 9. Pfister D, Siegemund M, Dell-Kuster S, et al. Cerebral perfusion in sepsis-associated delirium. Crit Care 2008; 12: R63. [CrossRef] 10. Oliveira CO, Ikuta N, Regner A. Outcome biomarkers following severe traumatic brain injury. Rev Bras Ter Intensiva 2008; 20: 411-421. [CrossRef] 11. Vos PE, Lamers KJ, Hendriks JC, et al. Glial and neuronal proteins in serum predict outcome after severe traumatic brain injury. Neurology 2004; 62: 1303-1310. [CrossRef] 12. Balan S, Leibovitz A, Zila SO, et al. The relation between the clini-cal subtypes of delirium and the urinary level of 6-SMT. J Neuro-psychiatry Clin Neurosci 2003; 15: 363-366. [CrossRef] 13. van der Cammen TJ, Tiemeier H, Engelhart MJ, Fekkes D. Abnormal neurotransmitter metabolite levels in Alzheimer patients with a de-lirium. Int J Geriatr Psychiatry 2006; 21: 838-843. [CrossRef] 14. Marcantonio E, Ta T, Duthie E, Resnick NM. Delirium severity and psychomotor types: their relationship with outcomes after hip fracture repair. J Am Geriatr Soc 2002; 50: 850-857. [CrossRef]